In addition to its fast track status for HCC, RZ-001 has been approved for compassionate use under the US regulator’s Expanded Access Program (EAP) for patients with glioblastoma. This programme is being carried out at Harvard University Hospital, providing access to investigational treatment outs...
Comp 1: Compensation Concepts and Principles FAST TRACK "The Fast Track program I attended was very intensive and specific to my needs. I was able to take minimal time off work to learn career- enhancing skills that have proven to make me more invaluable in my office." - Executive ...
In an interview with OncLive® at the 2018 State of the Science Summit™ on Gastrointestinal Cancers, Singal, associate professor and medical director of the Liver Tumor Program and clinical chief of Hepatology at UT Southwestern Medical Center, discussed the evolving armamentarium of treatment opti...
The FDA has given RZ-001 fast track designation for HCC after demonstrating therapeutic activity in preclinical studies. RZ-001 suppresses hTERT expression in cancer cells while simultaneously inducing cytotoxic effects by integrating an HSVtk-encoding sequence into reprogrammed hTERT mRNA. RZ-001, an ...
Interactive ToolsSponsored Biomarker ConsortiumSubscribe Choose Specialty Biosimilars Brain Cancer Breast CancerBreast Cancer CAR T-cell Therapy COVID-19 Disparities in Cancer Care Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer ...
Montes HealthCare College is a medical assistant training program in Gardena, California. Ready to launch your medical career? Contact us.
Abstract An increasing evidence supports that cell competition, a vital selection and quality control mechanism in multicellular organisms, is involved in tumorigenesis and development; however, the mechanistic contributions to the association between cell competition and tumor drug resistance remain ill-defin...
As an alternative, the Cancer of the Liver Italian Program (CLIP) (A new prognostic system for, 1998) system evaluates liver function based on the Child-Pugh score, and considers tumour morphology (size and nodular involvement), the levels of α-fetoprotein (AFP) and the eventual presence of...
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma. Read More Nivolumab Plus Ipilimumab Improves OS and Response in Frontline uHCC Jordyn Sava January 25th 2025 Article The CheckMate 9DW study demonstrated the efficacy and manageable safet...
February 22nd 2025 RZ-001 Earns FDA Fast Track Designation in HCC September 12th 2024 Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress February 21st 2025 Key HCC Trial Data Establish the Role of Later-Line Cabozantinib and Raise Further Frontline Que...